Screening of serum samples from Wegener's granulomatosis patients using antibody microarrays
dc.contributor.author | Olle, Eric W. | en_US |
dc.contributor.author | Deogracias, Michael P. | en_US |
dc.contributor.author | Messamore, James E. | en_US |
dc.contributor.author | McClintock, Shannon D. | en_US |
dc.contributor.author | Barron, Adam G. | en_US |
dc.contributor.author | Anderson, Timothy D. | en_US |
dc.contributor.author | Johnson, Kent J. | en_US |
dc.date.accessioned | 2007-12-04T18:38:39Z | |
dc.date.available | 2008-11-05T15:05:43Z | en_US |
dc.date.issued | 2007-10 | en_US |
dc.identifier.citation | Olle, Eric W.; Deogracias, Michael P.; Messamore, James E.; McClintock, Shannon D.; Barron, Adam G.; Anderson, Timothy D.; Johnson, Kent J. (2007). "Screening of serum samples from Wegener's granulomatosis patients using antibody microarrays." PROTEOMICS - Clinical Applications 1(10): 1212-1220. <http://hdl.handle.net/2027.42/57410> | en_US |
dc.identifier.issn | 1862-8346 | en_US |
dc.identifier.issn | 1862-8354 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/57410 | |
dc.description.abstract | Wegener's Granulomatosis (WG) is an idiopathic granulomatosis autoimmune vasculitis that primarily affects small vessels and is associated with glomerulonephritis and pulmonary granulomatous vasculitis. Anti-neutrophil cytoplasmic auto-antibodies (cANCA) against proteinase-3 are used to identify WG, but ANCA titers are not present in some patients with the localized disease. The objective of this study was to develop an antibody array to help identify protein expression patterns in serum from patients with WG as compared to normals. The arrays were tested for limits of detection, background, and cross reactivity using standard proteins. The arrays were hybridized with either normal patient serum (n 14= 1430) or with serum samples from a population of WG patients (n 14= 1426) that were age and sex matched. Data analysis and curve fitting of the standard dilution series calculated r 2 values and determined a sensitivity of <50 14pg/mL for the majority of proteins. A total of 24 proteins were assessed. Several statistically significant increases ( p <0.05) were seen in the expression of: angiotensin converting enzyme-I, IFN-Γ, IL-8, s-ICAM-1 and s-VCAM in WG patients as compared to controls. Utilizing the antibody microarray technology has led to the identification of potential biomarkers of vascular injury in the serum of WG patients. | en_US |
dc.format.extent | 366738 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | WILEY-VCH Verlag | en_US |
dc.subject.other | Life Sciences | en_US |
dc.subject.other | Molecular Cell Biology | en_US |
dc.title | Screening of serum samples from Wegener's granulomatosis patients using antibody microarrays | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Medicine (General) | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | University of Michigan, Department of Pathology, Ann Arbor, MI, USA ; Safety Sciences, Pfizer Global Research & Development, Ann Arbor, MI, USA | en_US |
dc.contributor.affiliationum | University of Michigan, Department of Pathology, Ann Arbor, MI, USA | en_US |
dc.contributor.affiliationum | University of Michigan, Department of Pathology, Ann Arbor, MI, USA | en_US |
dc.contributor.affiliationum | University of Michigan, Department of Pathology, Ann Arbor, MI, USA | en_US |
dc.contributor.affiliationum | University of Michigan, Department of Pathology, Ann Arbor, MI, USA ; The University of Michigan School of Medicine, Department of Pathology, 1301 Catherine Rd., Ann Arbor, MI 48109-0602, USA Fax: +1-734-764-4308 | en_US |
dc.contributor.affiliationother | Discovery-Biomarkers Group, Pfizer Global Research & Development, Ann Arbor, MI, USA | en_US |
dc.contributor.affiliationother | Safety Sciences, Pfizer Global Research & Development, Ann Arbor, MI, USA | en_US |
dc.identifier.pmid | 21136620 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/57410/1/1212_ftp.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1002/prca.200600906 | en_US |
dc.identifier.source | PROTEOMICS - Clinical Applications | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.